Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial.

Diabetes Obes Metab · 2023 · PMC9742170 · PMID 36082522

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Arrhythmic events were not specifically evaluated in the original analysis and our analysis showed a trend towards an increased risk of arrhythmias, particularly among those without an implanted cardiac device.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.